Researchers remain perplexed on the role of the interplay between blood pressure and glucose status and the development of cardiovascular events like coronary artery disease and cerebrovascular disease. In a first-of-its-kind study, published in Diabetes Care, Japanese researchers discovered that cardiovascular risks gradually rose with increases in blood pressure regardless of the presence of and degree of a blood glucose abnormality -- providing insight on BP targets for hypertensive patients according to glucose status.
After a stroke, doctors can try to remove clots in blood vessels to keep blood flowing freely to the brain. But even though most of these procedures are successful, less than half of people have a successful recovery from the stroke. A new study published in the June 23, 2021, online issue of Neurology®, the medical journal of the American Academy of Neurology, sheds light on why that may be.
Statin use among patients with heart failure is associated with a 16% lower risk of developing cancer compared with non-statin users during an average of four years of follow-up, according to new research published in the European Heart Journal. In addition, the study found that statin use was associated with a 26% reduced risk of dying from cancer over the same period.
Research has found that training stroke survivors to walk at a faster speed during recovery can help improve the brain function that enables people to walk and perform another task simultaneously, known as dual-task walking.
High blood pressure is a risk factor for cognitive decline and dementia in older adults. Studies have shown that commonly prescribed high blood pressure medications, or antihypertensives, may have a positive, beneficial impact on cognitive function including memory. This is the first meta-analysis to compare the impact on memory over time associated with taking antihypertensives that cross the blood-brain barrier versus those that do not.
Between 40% and 80% of people in the U.S. with cardiovascular disease also have obstructive sleep apnea (OSA), yet it is underrecognized and undertreated in cardiovascular practice. Sleep apnea can cause a negative feedback loop whereby it worsens cardiovascular conditions, which then worsen the sleep apnea. OSA affects 30% to 50% of people with high blood pressure and is a risk factor for atrial fibrillation.
CLEVELAND: New findings from Cleveland Clinic researchers show for the first time that the gut microbiome impacts stroke severity and functional impairment following stroke. The results, published in Cell Host & Microbe, lay the groundwork for potential new interventions to help treat or prevent stroke. The research was led by Weifei Zhu, Ph.D., and Stanley Hazen, M.D., Ph.D., of Cleveland Clinic's Lerner Research Institute.
Individuals infected with HIV are more than twice as likely to die from sudden cardiac death (SCD) compared to the general population, and are more likely to have hearts compromised by fibrosis, a factor that may play a role in increasing their susceptibility to SCD, according to new findings from a UC San Francisco study.
Financial toxicity, the financial strain experienced by patients accessing health care, impacts a large population of cancer patients according to prior research. A new study, published in JACC: CardioOncology, finds financial toxicity is often greater among heart disease patients compared to cancer patients, and those with both conditions suffer the highest burden.
The number of people dying from cardiovascular disease (CVD) in Asia is increasing rapidly, with over half of all CVD deaths globally in 2019 occurring in Asian countries, according to a state-of-the-art review paper published in the inaugural issue of JACC: Asia. The data demonstrates an urgent need to understand the burdens and epidemiological features of CVD in Asian countries to develop localized CVD prevention strategies to combat the epidemic.